From the editors.
D001741:Black or African American / Q000235:genetics; D000698:Analgesia / Q000941:ethics / Q000379:methods; D026688:Bioethical Issues; D001675:Bioethics; D003242:Conscience; D004338:Drug Combinations; D026690:Ethics, Clinical; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D033183:Interdisciplinary Communication; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008108:Liver Diseases, Alcoholic / Q000601:surgery; D016031:Liver Transplantation / Q000941:ethics; D009014:Morals; D009488:Neurosciences / Q000941:ethics; D018802:Patient-Centered Care / Q000941:ethics / Q000379:methods; D018458:Persistent Vegetative State; D012942:Social Sciences; D014481:United States; D014486:United States Food and Drug Administration; D014850:Waiting Lists
D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate